Expand XLO Menu
XLO MENU

XLO Latest Press Releases

-- May 12, 2026 --

Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates Globe Newswire 7:30 AM

-- May 7, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- April 17, 2026 --

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 Globe Newswire 4:01 PM

-- April 16, 2026 --

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors Globe Newswire 7:30 AM

-- April 3, 2026 --

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- March 23, 2026 --

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 7:30 AM

-- March 17, 2026 --

Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting Globe Newswire 4:45 PM

-- March 12, 2026 --

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split Globe Newswire 8:30 AM

-- March 2, 2026 --

Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference Globe Newswire 8:00 AM
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- February 11, 2026 --

Xilio Therapeutics Announces Pricing of Underwritten Offering Globe Newswire 9:34 PM
Market Data Delayed 15 Minutes